WENDY HAALAND: Open Payments
NPI 1932296969 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 66 payments from 13 companies in 2025. Trend: 2023 $763 · 2024 $842 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $216 |
| Amgen Inc. | 12 | $174 |
| Lilly USA, LLC | 15 | $157 |
| Novo Nordisk Inc | 12 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Medtronic, Inc. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, VRAYLAR, EVENITY, QULIPTA, Ozempic, TRINTELLIX, OTEZLA, MINIMED 780G.
Industry payments across ND — which companies pay providers there.
